Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Hualan Biological Engineering Inc.
  6. News
  7. Summary
    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2021

08/29/2021 | 04:56am EST

Hualan Biological Engineering Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,288.596 million compared to CNY 1,386.540 million a year ago. Operating income was CNY 534.006 million compared to CNY 599.110 million a year ago. Net income was CNY 457.282 million compared to CNY 511.739 million a year ago. Basic earnings per share from continuing operations was CNY 0.2508 compared to CNY 0.2811 a year ago. Diluted earnings per share from continuing operations was CNY 0.2512 compared to CNY 0.2811 a year ago.


ę S&P Capital IQ 2021
All news about HUALAN BIOLOGICAL ENGINEERING INC.
2021Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended S..
CI
2021Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended Jun..
CI
2021Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for the Ye..
CI
2021Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended..
CI
2021HUALAN BIOLOGICAL ENGINEERING : to Produce Russia's Sputnik COVID-19 Vaccine in China
MT
2021Hualan Biological Engineering Inc. Proposes Final Dividend for 2020
CI
2021Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended Dec..
CI
2020LG shakes up loss-making phone business, to outsource lower-end models
RE
2020Samsung may discontinue high-end Galaxy Note smartphones - sources
RE
2020Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended S..
CI
More news
Financials
Sales 2021 5 812 M 917 M 917 M
Net income 2021 1 875 M 296 M 296 M
Net cash 2021 1 805 M 285 M 285 M
P/E ratio 2021 25,6x
Yield 2021 1,42%
Capitalization 48 163 M 7 598 M 7 599 M
EV / Sales 2021 7,98x
EV / Sales 2022 6,48x
Nbr of Employees 2 887
Free-Float 52,7%
Chart HUALAN BIOLOGICAL ENGINEERING INC.
Duration : Period :
Hualan Biological Engineering Inc. Technical Analysis Chart | 002007 | CNE000001JN8 | MarketScreener
Technical analysis trends HUALAN BIOLOGICAL ENGINEERING INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 26,40 CNY
Average target price 41,22 CNY
Spread / Average Target 56,1%
EPS Revisions
Managers and Directors
Kang An Chairman & General Manager
Jun Min Xie Chief Financial Officer & Board Secretary
Chao Yuan Ma Chairman-Supervisory Board
Pei Tang Huang Independent Director
Yun Long Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
HUALAN BIOLOGICAL ENGINEERING INC.-9.40%7 598
GILEAD SCIENCES, INC.-5.65%85 938
REGENERON PHARMACEUTICALS-2.71%64 971
VERTEX PHARMACEUTICALS3.86%57 990
WUXI APPTEC CO., LTD.-9.18%49 645
BIONTECH SE-42.79%35 624